drugset / Trial / NCT02182934

Efficacy of Ginsana in Improving Half-time Hemoglobin Re-oxygenation in Healthy Recreational Sports People

NCT02182934 ↗

Phase 2 Completed 26 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the efficacy of Ginsana in improving hemoglobin re-oxygenation in healthy, recreational sports people and to assess the safety of the product.

Timeline

Start
1999-11
Primary completion
2000-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject GINSANA Unknown — —

Indications

No indication recorded.